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SUMMARY
Objective: Gestational trophoblastic disease after an early elective medical abortion with the mifepristone/
misoprostol combination (MMC) is rare.
Case Report: We report a case of a young woman who was at 6–7 weeks of gestation who requested a medical
abortion. The pretreatment ultrasonogram indicated a normal pregnancy. Passage of tissue ensued after the
MMC, with good recovery. Postabortal ultrasonogram on day 14 showed the presence of intracavitary content.
The patient declined our suggestion of serial ultrasonographic surveillance, and she was later lost to follow-
up. Fifty days after the initial treatment, she again presented to our hospital with intermittent bleeding and
an increase in the blood flow signal with a low resistance index in the uterus on color Doppler ultrasonography.
After curettage, she was diagnosed as having a partial hydatidiform mole; she had complete regression of beta-
human chorionic gonadotropin, monitored for 1 week after the evacuation.
Conclusions: Obstetricians should be aware of the possibility of a partial hydatidiform mole after a medical
abortion. [Taiwanese J Obstet Gynecol 2004;43(4):232–234]
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Introduction
Mifepristone (RU-486) is a synthetic steroid that acts as
a competitive blocker of both progesterone and cortisone
receptors [1]. Misoprostol is a prostaglandin analog
used to prevent gastric ulcers induced by aspirin or
nonsteroidal anti-inflammatory drugs [2]. The mifepri-
stone/misoprostol combination (MMC) is an effective
method for terminating an early pregnancy [1–3], be-
cause mifepristone increases myometrial sensitivity
to prostaglandin in pregnant women [4]. Bygdeman et
al reported that MMC can achieve a 96% complete
abortion rate, while producing complications of heavy
vaginal bleeding in only 0.8% and infections in 0.7% [2].
A partial hydatidiform mole, which is due to a gen-
etically abnormal conception, is an abnormal feto-
placental development with four microscopic fea-
tures: two populations of villi; enlarged villi (* 3–4 mm)
with central cavitation; irregular villi with geographic,
scalloped borders with trophoblast inclusions; and
trophoblast hyperplasia (usually focal and involving
syncytiotrophoblasts) [5].
Herein, we present a case of unusual gestational
trophoblastic disease in a patient who underwent an
early elective medical abortion with MMC.
Case Report
A 32-year-old multigravid woman requested a medical
abortion at the obstetrics and gynecology clinic of Tai-
pei Medical University–Municipal Wan Fang Hospital.
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Pretreatment ultrasound examination at a local clinic
was consistent with a 6- to 7-week pregnancy. The pa-
tient was allowed to receive MMC. She took 600 mg of
oral mifepristone first and then 600 +g of oral miso-
prostol 48 hours later. She underwent post-treatment
ultrasound examination on day 14 after MMC, when
she reported vaginal passage of tissue and mild painless
vaginal spotting during recovery. The postabortal ultra-
sonogram showed no gestational sac but a hetero-
geneous pattern of echoes and positive intracavitary
content. We suspected that she had had an incomplete
abortion. However, she declined our suggestion of
serial ultrasonographic monitoring and was lost to
follow-up. Fifty days after the initial treatment, she pre-
sented to our clinic again with a history of intermittent
vaginal bleeding and a positive pregnancy test. Color
Doppler ultrasonographic examination showed that
she had a rich blood flow signal and low blood flow
index (resistance index [RI], 0.36; pulsatile index, 0.49)
in the uterus (Figure 1).
The patient underwent therapeutic dilatation and
curettage. The histopathologic features of the specimen
showed endometrial tissue in the proliferative phase
and abundant necrotic chorionic villi and decidual
tissue. We also noted chorionic villi with frequent tro-
phoblast hyperplasia (Figure 2). Thus, we diagnosed
that our patient had a partial hydatidiform mole.
Beta-human chorionic gonadotropin (`-hCG) levels
became normal 1 week after curettage. The findings of
weekly repeated surveillance of ` -hCG remained normal
over the subsequent 4 weeks.
Discussion
Medical abortion with MMC has become popular.
Taking misoprostol 36–48 hours after receiving mife-
pristone is the most common regimen used to terminate
a pregnancy of up to 49 days [1].
Determining an accurate gestational age is impor-
tant because the rate of successful abortion decreases
with advancing pregnancy [1]. In patients who request
an early medical abortion, the pregnancy needs to be
confirmed with hCG assays and the gestational age
should be estimated ultrasonographically [6]. In our
case, the pregnancy test was positive and the ultra-
sonographic gestational age was confirmed to be 6–7
weeks. These examinations were performed in a local
clinic. Based on the pretreatment ultrasonogram, we
suspected the presence of gestational trophoblastic
disease rather than a normal pregnancy or a twin preg-
nancy with one normal gestational sac and gestational
trophoblastic disease.
Figure 1. Color Doppler ultrasonogram shows a rich blood
flow signal and low blood flow index (resistance index, 0.36;
pulsatile index, 0.49) in the uterus.
Figure 2. Pathologic examination of the curettage specimen
shows many chorionic villi with marked trophoblast prolifer-
ation (hematoxylin & eosin, = 100).
Close follow-up of patients allows clinicians to con-
firm whether the abortion is complete without com-
plications [6]. The ultrasonogram obtained on day 14
after the abortion showed the absence of a gestational
sac but the presence of intracavitary content. Therefore,
we decided to treat the patient. Blohm et al reported an
83% complete rate of early miscarriage managed by the
expectant method [7]. If expectant management fails or
its outcome is uncertain, examinations using transvaginal
ultrasonography and `-hCG assays can help with the
diagnosis [6]. In our case, the patient declined serial
ultrasonographic monitoring and was lost to follow-up
despite our warning of the potential for a malignant
change in her condition.
Distinguishing the products of curettage is also
important because a partial hydatidiform mole has
malignant potential (e.g. choriocarcinoma) to a true
neoplasm that can have an aggressive outcome [5]. In
our case, the histopathologic feature of the specimen
revealed many chorionic villi with marked trophoblast
proliferation. Thus, a diagnosis of partial hydatidiform
mole was suspected.
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Our patient recovered without vaginal spotting and
`-hCG had completely regressed 1 week after curettage.
Unlike methotrexate, MMC has no anti-metabolic ef-
fect in the treatment of trophoblastic disease. Volume
shrinkage of the intrauterine content with mifepristone
may play a role in reducing the risk of metastasis [8]. Jin
et al reported four cases with malignant gestational
trophoblastic tumors after a mifepristone abortion and
found a rich blood flow signal and low blood flow RI
(< 0.5) [9]. Based on the ultrasonographic report for
our case, we suspected the diagnosis of a partial hydat-
idiform mole (RI, 0.36). Therefore, we performed dila-
tation and curettage to confirm the diagnosis and to
follow the gestational trophoblastic disease after the
medical abortion with MMC. Signs of an abnormal
abortion on day 14 after MMC included failure of ex-
pectant management, presentation of vaginal bleeding,
and an increase in blood flow signal with a low RI on
color Doppler ultrasound.
Based on the findings from this case and in the lit-
erature, we suggest that obstetricians should be aware
of the possibility of a pre-existing partial hydatidiform
mole after a medical abortion, and that careful measures
should be taken to avoid possible persistent gestational
trophoblastic disease.
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